1. Home
  2. RSSS vs ELTX Comparison

RSSS vs ELTX Comparison

Compare RSSS & ELTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RSSS
  • ELTX
  • Stock Information
  • Founded
  • RSSS 2006
  • ELTX 2011
  • Country
  • RSSS United States
  • ELTX United States
  • Employees
  • RSSS N/A
  • ELTX N/A
  • Industry
  • RSSS Business Services
  • ELTX Biotechnology: Pharmaceutical Preparations
  • Sector
  • RSSS Consumer Discretionary
  • ELTX Health Care
  • Exchange
  • RSSS Nasdaq
  • ELTX Nasdaq
  • Market Cap
  • RSSS 86.4M
  • ELTX 49.7M
  • IPO Year
  • RSSS N/A
  • ELTX 2021
  • Fundamental
  • Price
  • RSSS $2.68
  • ELTX $4.16
  • Analyst Decision
  • RSSS Strong Buy
  • ELTX Buy
  • Analyst Count
  • RSSS 1
  • ELTX 2
  • Target Price
  • RSSS $6.00
  • ELTX $10.00
  • AVG Volume (30 Days)
  • RSSS 30.4K
  • ELTX 16.1K
  • Earning Date
  • RSSS 11-07-2024
  • ELTX 11-07-2024
  • Dividend Yield
  • RSSS N/A
  • ELTX N/A
  • EPS Growth
  • RSSS N/A
  • ELTX N/A
  • EPS
  • RSSS N/A
  • ELTX N/A
  • Revenue
  • RSSS $44,623,899.00
  • ELTX N/A
  • Revenue This Year
  • RSSS $13.76
  • ELTX N/A
  • Revenue Next Year
  • RSSS $9.92
  • ELTX N/A
  • P/E Ratio
  • RSSS N/A
  • ELTX N/A
  • Revenue Growth
  • RSSS 18.35
  • ELTX N/A
  • 52 Week Low
  • RSSS $2.21
  • ELTX $2.96
  • 52 Week High
  • RSSS $3.50
  • ELTX $11.45
  • Technical
  • Relative Strength Index (RSI)
  • RSSS 50.43
  • ELTX 40.82
  • Support Level
  • RSSS $2.55
  • ELTX $4.05
  • Resistance Level
  • RSSS $2.75
  • ELTX $4.89
  • Average True Range (ATR)
  • RSSS 0.10
  • ELTX 0.28
  • MACD
  • RSSS -0.00
  • ELTX -0.06
  • Stochastic Oscillator
  • RSSS 53.57
  • ELTX 27.37

About RSSS Research Solutions Inc

Research Solutions Inc is a holding company. The company provides a cloud-based SaaS research intelligence platform consisting of proprietary software and Internet-based interfaces. Its platform also allows customers to find and download digital versions of STM articles. Platforms and Transactions are packaged as a single solution that enables life science and other research-intensive organizations to speed up research and development activities. The company platform allows customers to initiate orders, manage transactions, automate authentication, obtain reports, and connect seamlessly to corporate intranets.

About ELTX Elicio Therapeutics Inc.

Elicio Therapeutics Inc is a clinical-stage biotechnology company pioneering the development of cancer immunotherapies for patients with limited treatment options and poor outcomes. Its proprietary Amphiphile, or AMP, platform delivers investigational immunotherapeutics directly to the brain center of the immune system the lymph nodes. Its focus is the development of cancer immunotherapies against biologically validated but hard-to-drug targets that can be activated through lymph node trafficking. Elicio is engineering lymph node-targeted AMPlifiers, immunomodulators, adjuvants, and vaccines for an array of aggressive cancers. It has developed its cancer vaccine product candidates to target biologically validated tumor mutation drivers using known neoantigens.

Share on Social Networks: